Distamycin a or stallimycin

duramycin.

G3-VC-PAB-DMEA-Duocarmycin DM (Compound LD-1) is a duocarmycin-based linker molecule that can be used for ADC preparation

Kasugamycin, 50mg/ml in dist water, 25ml

MA-PEG4-VC-PAB-DMEA-duocarmycin DM is a part of the antibody conjugated active molecule ADC (drug linker conjugate for ADC), which is composed of DNA groove alkylating agent Duocarmycin DM and linker MA-PEG4-vc-PAB-DMEA.

PrEST Antigen PDCL phosducin-like, 100ul UN 1687 6.1 PG2

PrEST Antigen PDCL phosducin-like, 100ul UN 1687 6.1 PG2

PrEST Antigen PDCL2 phosducin-like 2, 100ul UN 1687 6.1 PG2

Reveromycin A.

A macrolide antibiotic that inhibits bacterial protein synthesis (IC₅₀ = 0.26 &microM) by targeting the 50S ribosomal subunit effective against M.

A selective, potent, and cell-permeable inhibitor of mTOR (IC₅₀ = 4.3 nM) which blocks signaling through both mTORC1 and mTORC2 induces G1 cell cycle arrest in both rapamycin-sensitive and rapamycin-resistant cancer cell lines and

A selective, potent, and cell-permeable inhibitor of mTOR (IC₅₀ = 4.3 nM) which blocks signaling through both mTORC1 and mTORC2 induces G1 cell cycle arrest in both rapamycin-sensitive and rapamycin-resistant cancer cell lines and

A selective, potent, and cell-permeable inhibitor of mTOR (IC₅₀ = 4.3 nM) which blocks signaling through both mTORC1 and mTORC2 induces G1 cell cycle arrest in both rapamycin-sensitive and rapamycin-resistant cancer cell lines and